How can the LIO-1 study help to overcome challenges in gynecological cancer? An interview with Dr Erika Hamilton

Written by Erika Hamilton (Tennessee Oncology, TN, USA)

gynecological cancer

Please can you introduce yourself, your research background and current research interests. My name is Dr Erika Hamilton and I lead the Breast Cancer and Gynecologic Cancer Research Program for Sarah Cannon Research Institute at Tennessee Oncology in Nashville, Tennessee (TN, USA). I have been here for about 7.5 years and I am heavily involved in clinical trials, both from a Phase II and III standpoint as well as our drug development unit in Phase I. What are the current challenges that need to be overcome in gynecological cancer treatment? Gynecological cancers span several tumor types, including endometrial cancer (cancer...

To view this content, please register now for access

It's completely free